Endothelial nitric oxide synthase haplotypes are associated with preeclampsia in Maya mestizo women

Disease Markers

Volumn 31, Issue 2, 2011, Pages 83-89

  Díaz Olguín, Lizbeth ^a   Coral Vázquez, Ramón Mauricio ^a   Canto Cetina, Thelma ^b   Canizales Quinteros, Samuel ^c   Ramírez Regalado, Belem ^a   Fernández, Genny ^d,e   Canto, Patricia ^a  

^a CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

eNOS haplotypes.; maya mestizo women; polymorphisms of eNOS; Preeclampsia

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ARTICLE; BODY MASS; CASE CONTROL STUDY; DISEASE ASSOCIATION; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 80052682474     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0804     Document Type: Article

References (46)

1. J.M. Roberts and D.W. Cooper, Pathogenesis and genetics of pre-eclampsia, Lancet 357 (2001), 53-56. (Pubitemid 32056505)
2. P. López-Jaramillo, J.P. Casas and N. Serrano, Preeclampsia: from epidemiological observations to molecular mechanisms, Braz JMed Biol Res 34 (2001), 1227-1235. (Pubitemid 33014489)
3. K.Y. Lain and J.M. Roberts, Contemporary concepts of the pathogenesis and management of preeclampsia, JAMA 287 (2002), 3183-3186. (Pubitemid 34686089)
4. J.M. Roberts, R.N. Taylor, T.J. Musci, G.M. Rodgers, C.A. Hubel and M.K. Mc Laughlin, Preeclampsia: an endothelial cell disorder, Am J Obstet Gynecol 161 (1989), 1200-1204. (Pubitemid 20007682)
5. J.M.Robertsand C.W.G.Redman, Pre-eclampsia: morethan pregnancy-induced hypertension, Lancet 341 (1993), 1447-1451.
6. M.W. Radomski, R.M. Palmer and S. Moncada, Endogenous nitric oxide inhibits human platelet adhesion to vascular en-dothelium, Lancet 2 (1987), 1057-1058. (Pubitemid 17154788)
7. P. Kubes, M. Suzuki and D.N. Granger, Nitric oxide: an en-dogenous modulator of leukocyte adhesion, Proc Natl Acad Sci USA 88 (1991), 4651-4655. (Pubitemid 21914599)
8. V.M. Bolotina, S. Najibi, J.J. Palacino, P.J. Pagano and R.A. Cohen, Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle, Nature 368 (1994), 850-853. (Pubitemid 24137748)
9. U. Forstermann and T. Munzel, Endothelial nitric oxide syn-thase in vascular disease: from marvel to menace, Circulation 113 (2006), 1708-1714.
10. C.P. Weiner, R.G. Knowles and S. Moncada, Induction ofnitric oxide synthases early in pregnancy, Am J Obstet Gynecol 171 (1994), 838-843. (Pubitemid 24312374)
11. D.J. Williams, P.J. Vallance, G.H. Neild,J.A. Spencerand F.J. Imms, Nitric oxide-mediated vasodilation in human pregnan-cy, Am J Physiol 272 (1997), H748-H752.
12. S.P. Seligman, J.P. Buyon, R.M. Clancy, B.K. Young and S.B. Abramson, The role of nitric oxide in the pathogenesis of preeclampsia, Am J Obstet Gynecol 171 (1994), 944-948. (Pubitemid 24341474)
13. V.C. Sandrim, A.C. Palei, I.F. Metzger, V.A. Gomes,R.C. Cav-alli and J.E. Tanus-Santos, Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia, Hypertension 52 (2008), 402-407.
14. PA. Marsden, H.H. Heng, S.W. Scherer, R.J. Stewart, A.V. Hall, X.M. Shi, L.C. Tsui and K.T. Schappert, Structure and chromosomal localization of the human constitutive endothe-lial nitric oxide synthase gene, J Biol Chem 268 (1993), 17478-17488. (Pubitemid 23236991)
15. Y. Wang, Y. Gu, Y Zhang and D.F. Lewis, Evidence of en-dothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia, Am J Obstet Gynecol 190 (2004), 817-824. (Pubitemid 38406799)
16. A. Molvarec, A. Vér, A. Fekete, K. Rosta, L. Derzbach, Z. Derzsy, I. Karádi and J. Jr. Rigó, Association between estro-gen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia, Hypertens Res 30 (2007), 205-211. (Pubitemid 46605444)
17. A. Molvarec, A. Jermendy, B. Nagy, M. Kovács, T. Várkonyi, P. Hupuczi, Z. Prohászka and J. Jr. Rigó, Association between tumor necrosis factor (TNF)-alpha G-308A gene polymor-phism and preeclampsia complicated by severe fetal growth restriction, Clin Chim Acta 392 (2008), 52-57.
18. K. Rosta, A. Molvarec, A. Enzsöly, B. Nagy, Z. Rónai, A. Fekete, M. Sasvári-Székely, J. Jr. Rigó and A. Vér, Association of extracellular superoxide dismutase (SOD3) Ala40Thr gene polymorphism with pre-eclampsia complicated by severe fetal growth restriction, Eur J Obstet Gynecol Reprod Biol 142 (2009), 134-138.
19. J.E. Tanus-Santos, M. Desai and D.A. Flockhart, Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants, Pharmacogenetics 11 (2001), 719-725. (Pubitemid 33078242)
20. N.C. Serrano, J.P. Casas, L.A. D́az, C. Páez, C.M. Mesa, R. Cifuentes, A. Monterrosa, A. Bautista, E. Hawe, A.D. Hin-gorani, P. Vallance and P. López-Jaramillo, Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study, Hypertension 44 (2004), 702-707. (Pubitemid 39435241)
21. V.C. Sandrim, A.C. Palei, R.C. Cavalli, F.M. Araújo, E.S. Ramos, G. Duarte and J.E. Tanus-Santos, e NOS haplotypes as-sociated with gestational hypertension or preeclampsia, Phar-macogenomics 9 (2008), 1467-1473.
22. V.C. Sandrim, A.C Palei, J.T. Sertorio, R.C. Cavalli, G. Duarte and J.E. Tanus-Santos, Effects of e NOS polymor-phisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia, Mol Hum Reprod 16 (2010), 506-510.
23. R. Landau, H.G. Xie, V. Dishy, A.J. Wood, C.M. Stein and R.M. Smiley, No association of the Asp298 variant of the endothelial nitric oxide synthase gene with preeclampsia, Am JHypertens 17 (2004), 391-394. (Pubitemid 38529959)
24. A. Seremak-Mrozikiewicz, K. Drews and P.M. Mrozikiewicz, The-786T/C polymorphism of the endothelial nitric oxide synthase gene in preeclampsia, Eur J Obstet Gynecol Reprod Biol138 (2008), 118-119. (Pubitemid 351608102)
25. R. Juárez-Velázquez, P. Canto, T. Canto-Cetina, H. Rangel-Villalobos, H. Rosas-Vargas, M. Rodŕguez, S. Canizales-Quinteros, A.C. Velázquez Wong, R.M. Ordoñez-Razo, G. Vilchis-Dorantes and R.M. Coral-Vázquez, Analysis ofpoly-morphisms in genes (AGT, MTHFR, GPIIIa, and GSTP1) as-sociated with hypertension, thrombophilia and oxidative stress in Mestizo and Amerindian populations of México, Dis Mark-ers 28 (2010), 323-331.
26. P. Canto, T. Canto-Cetina, R. Juarez-Velazquez, H. Rosas-Vargas, H. Rangel-Villalobos, S. Canizales-Quinteros, A.C. Velázquez-Wong, M.T. Villarreal-Molina, G. Fernández and R. Coral-Vázquez, Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women, Hypertens Res 31 (2008), 1015-1019. (Pubitemid 351895046)
27. Report of the National High Blood Pressure Education Pro-gram Working Group on High Blood Pressure in Pregnancy, Am J Obstet Gynecol 183 (2000), S1-S22.
28. B. Kempter and K. Grossbadern, Quick preparation of high molecular weight DNA by freezing, Trends Genet 8 (1992), 226.
29. S.M. Roth, S.M. Williams, L. Jiang, K.S. Menon and J.J. Jeka, Susceptibility genes for gentamicin-induced vestibular dysfunction. J Vestib Res 18 (2008), 59-68.
30. N. Duran and J. Couoh, Epidemiloǵa de la preeclampsia-eclampsia de una muestra en Yucatán, Ginec Obstet Mex 67 (1999), 571-577.
31. S. Pértegas D́az and S. Pita Fernández, Unidad de Epi-demioloǵa Cĺnica y Bioestad́stica. Complexo Hospitalario-Universitario Juan Canalejo. A Coruña (España) Cad Aten Primaria 10 (2003), 59-63.
32. H. Rosas-Vargas, A. Flores-Segura, B. Guizada-Claure, G. Vargas-Alarcón, J. Granados, F. Salamanca and R. Coral-Vázquez, Endothelial nitric oxide synthase gene polymor-phism in the Indian and Mestizo populations of Mexico, Hum Biol 75 (2003), 91-96. (Pubitemid 36418453)
33. J.P. Casas, L.E. Bautista, S.E. Humphries and A.D. Hingo-rani, Endothelial nitric oxide synthase genotype andischaemic heart disease: metaanalysis of 26 studies involving 23028 subjects, Circulation 109 (2004), 1359-1365. (Pubitemid 38387821)
34. T. Canto-Cetina, S. Canizales-Quinteros, E. dela Chesnaye, R. Coral-Vázquez, J.P. Méndez and P. Canto, Analysis of C-850T and G-308A polymorphisms of the tumornecrosis factor-alpha gene in Maya-Mestizo women with preeclampsia, Hypertens Pregnancy 26 (2007), 283-291. (Pubitemid 47295351)
35. M.D. Savvidou, P.J. Vallance, K.H. Nicolaides and A.D. Hin-gorani, Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy, Hypertension 38 (2001), 1289-1293. (Pubitemid 34033404)
36. M. Tesauro, W.C. Thompson, P. Rogliani, L. Qi, PP. Chaud-hary and J. Moss, Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severi-ty of cardiopulmonary diseases: cleavage of proteins with as-partate vs. glutamate at position 298, Proc Natl Acad Sci USA 6 (2000), 2832-2835. (Pubitemid 30159257)
37. A. Persu, M.S. Stoenoiu, T. Messiaen, S. Davila, C. Robino, O. El-Khattabi, M. Mourad, S. Horie, O. Feron, J.L. Balligand, R. Wattiez, Y. Pirson, D. Chauveau, X.M. Lens and O. Devuyst, Modifier effect of e NOS in autosomal dominant polycystic kidney disease, Hum Mol Genet 11 (2002), 229-241. (Pubitemid 34173352)
38. T.A. Fairchild, D. Fulton, J.T. Fontana, J.P. Gratton, T.J. Mc-Cabeand WC. Sessa, Acidichydrolysis as amechanismforthe cleavage of the Glu(298)3Asp variant of human endothelial nitric-oxide synthase, J Biol Chem 276 (2001), 26674-26679.
39. D.M. Mc Donald, N.J. Alp and K.M. Channon, Func-tional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells, Pharmacogenetics 14 (2004), 831-839. (Pubitemid 40054338)
40. M. Nakayama, H. Yasue, M. Yoshimura, Y Shimasaki, K. Kugiyama, H. Ogawa, T. Motoyama, Y Saito, Y Ogawa, Y Miyamoto and K. Nakao, T-7863C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm, Circulation 99 (1999), 2864-2870. (Pubitemid 29258973)
41. Y. Miyamoto, Y. Saito, M. Nakayama, Y Shimasaki, T. Yoshimura, M. Yoshimura, M. Harada, N. Kajiyama, I. Kishi-moto, K. Kuwahara, J. Hino, E. Ogawa, I. Hamanaka, S. Kami-tani, N. Takahashi, R. Kawakami, K. Kangawa, H. Yasue and K. Nakao, Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a-786T3C mutation associated with coronary spastic angina, Hum Mol Genet 9 (2000), 2629-2637.
42. N. Jeerooburkhan, L.C. Jones, S. Bujac, J.A. Cooper, G.J. Miller, P. Vallance, S.E. Humphries and A.D. Hingorani, Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease, Hypertension 38 (2001), 1054-1061. (Pubitemid 34252805)
43. T. Tsukada, K. Yokoyama, T. Arai, S Hara, A. Yamada, Y. Kawaguchi, T. Hosoya and J. Igari, Evidence of association of the ec NOS gene polymorphism with plasma NO metabolite levels in humans, Biochem Biophys Res Commun 245 (1998), 190-193. (Pubitemid 28414268)
44. X.L. Wang, A.S. Sim, M.X. Wang, G.A. Murrell, B. Trudinger and J. Wang, Genotype dependent and cigarette specific ef-fects on endothelial nitric oxide synthase gene expression and enzyme activity, FEBS Lett 471 (2000), 45-50. (Pubitemid 30173290)
45. Y. Yoon, J. Song and S.H. Hong, Plasma nitric oxide con-centrations and nitric oxide synthase gene polymorphisms in coronary artery disease, Clin Chem 46 (2000), 1626-1230.
46. V.C. Sandrim, A.C. Palei, M.R. Luizon, T.C. Izidoro-Toledo, R.C. Cavalli and J.E. Tanus-Santos, eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension, Pharmacogenomics J 10 (2010), 40-45.